GSK probing claims of improper conduct in Iraq
08/04/2014 2:44 am EDT

share with your network:

GlaxoSmithKline (GSK) has said it is investigating allegations of improper conduct in Iraq, nine months after China began a corruption probe into the local operations of the UK’s largest drugmaker, Bloomberg has reported. “These allegations relate to a small number of individuals,” the London-based company said. “However, we are investigating whether there has been any improper conduct. We have zero tolerance for unethical or illegal behaviour.” In Iraq, Glaxo hired 16 government-employed doctors and pharmacists as paid sales representatives, the Wall Street Journal reported, citing e-mails from an unidentified person familiar with Glaxo’s Mideast operations. Glaxo’s pharmaceutical operations employ fewer than 60 people in Iraq, according to the company.

About the Author

share with your network:

Share your view

© 1996-2016 Media quest FZ LLC A media and entertainment company
Middle East Main Office
[email protected]
© 2016 Dubai Business | Ameinfo . All rights Reserved.